Read a new publication from Oncowitan: An in silico study aimed at identifying the binding sites on ribosomal proteins L11 and L15 within the 80S human ribosome for the camptothecins. The family includes three major anticancer drugs largely used to treat advanced solid tumors. A new potential target for these drugs has been identified.

Interaction of camptothecin anticancer drugs with ribosomal proteins L15 and L11: A molecular docking study, Molecules (2023)

Read here

Categories: News-Publications